AHA Releases New Statement on Diagnosing, Managing Hypertensive Disorders of Pregnancy

December 15, 2021

Released on Dec. 15, the latest scientific statement from the American Heart Association provides a comprehensive overview of the available evidence on topics related to diagnosis, management, and pharmacotherapy for hypertension during pregnancy.

Renal Denervation Plus Antihypertensive Agents Could Further Reduce Blood Pressure

November 05, 2021

Results of the 6-month follow-up from RADIANCE-HTN TRIO suggest the addition of antihypertensive medications following renal denervation could contribute to further blood pressure lowering in patients with treatment-resistant hypertension.

The Role of Health Systems in Promoting Adherence to Hypertension Treatments

October 26, 2021

Gregory Weiss, MD, provides perspective on a recent scientific statement from the AHA outlining the role of health systems in promoting optimal adherence to hypertension therapies and helping patients achieve treatment goals.